A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing.
Shengpei Chen,Tze Kin Lau,Chunlei Zhang,Chenming Xu,Zhengfeng Xu,Ping Hu,Jian Xu,Hefeng Huang,Ling Pan,Fuman Jiang,Fang Chen,Xiaoyu Pan,Weiwei Xie,Ping Liu,Xuchao Li,Lei Zhang,Songgang Li,Yingrui Li,Xun Xu,Wei Wang,Jun Wang,Hui Jiang,Xiuqing Zhang
DOI: https://doi.org/10.1002/pd.4110
2013-01-01
Prenatal Diagnosis
Abstract:Objective To report the feasibility of fetal chromosomal deletion/duplication detection using a novel bioinformatic method of low coverage whole genome sequencing of maternal plasma. Method A practical method Fetal Copy-number Analysis through Maternal Plasma Sequencing (FCAPS), integrated with GC-bias correction, binary segmentation algorithm and dynamic threshold strategy, was developed to detect fetal chromosomal deletions/duplications of >10Mb by low coverage whole genome sequencing (about 0.08-fold). The sensitivity/specificity of the resultant FCAPS algorithm in detecting deletions/duplications was firstly assessed in silico and then tested in 1311 maternal plasma samples from those with known G-banding karyotyping results of the fetus. Results Deletions/duplications, ranged from 9.01 to 28.46Mb, were suspected in four of the 1311 samples, of which three were consistent with the results of fetal karyotyping. In one case, the suspected abnormality was not confirmed by karyotyping, representing a false positive case. No false negative case was observed in the remaining 1307 low-risk samples. The sensitivity and specificity for detection of >10-Mb chromosomal deletions/duplications were100% and 99.92%, respectively. Conclusion Our study demonstrated FCAPS has the potential to detect fetal large deletions/duplications (>10Mb) with low coverage maternal plasma DNA sequencing currently used for fetal aneuploidy detection. (c) 2013 John Wiley & Sons, Ltd.